Natural Health Stock Slips Post Q2 Earnings, Revenues Decline Y/Y
NHTC's stock slipped after reporting second-quarter 2026 earnings, with revenues declining year over year. The quarter reflected weak Greater China demand, regulatory uncertainty and Hong Kong disruptions, while restructuring lowered costs.
Why it matters — A NHTC watcher would care because weak Greater China demand, regulatory uncertainty and Hong Kong disruptions are weighing on revenues, even as restructuring helps reduce costs.